Cell MedX Corp. (OTC PINK: CMXC), (the “Company”) has become aware of a paid report on the Company prepared and published by The Moskowitz Report dated Winter 2015, and additional reports on the Company prepared by James E. Brumley as…
LAS VEGAS, NV–Cell MedX Corp. (OTC: CMXC), (the “Company”) announced today that the Company has engaged The Metabolomics Innovation Centre at the University of Alberta (“TMIC”) to conduct metabolomics profiling of blood samples collected during the discovery phase of the…
Las Vegas, Nevada, January 5, 2015, Cell MedX Corp. (OTC:CMXC), (the “Company”) announced today that the Company has scheduled the commencement of its pilot trial of the e-balance Technology for January 9, 2015. The trial will be conducted on human…